Trial Profile
A study investigating effect of interpatient variability on platelet reactivity in patients treated with Prasugrel and ticagrelor.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Abdominal aortic aneurysm; Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Sickle cell anaemia; Stroke
- Focus Pharmacodynamics